PMN Stock Analysis: Buy, Sell, or Hold?
PMN - ProMIS Neurosciences Inc. Common Shares (ON)
$15.75
4.03 (34.39%)
▲
5d:
+8.7%
30d:
+49.57%
90d:
+41.89%
HOLD
MODERATE Confidence
Analysis Updated: Jul 27, 2026 12:00 AM ET
Earnings: Aug 12, 2026
14d
Get Alerted When PMN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD - EXTENDED: PMN is 8.5% above its trading range ($14.51). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
📊 HOLD - EXTENDED: PMN is 8.5% above its trading range ($14.51). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
In-depth Analysis How we analyze
Valuation Analysis: PMN is currently trading at $15.75, which is considered extended relative to its 30-day fair value range of $11.40 to $14.51.
Technical Outlook: Technically, PMN is in a downtrend. Immediate support is located at $11.25, while resistance sits at $16.68. The stock is showing strong short-term momentum, up 34.4% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $32.40 (+176.5%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, PMN is in a downtrend. Immediate support is located at $11.25, while resistance sits at $16.68. The stock is showing strong short-term momentum, up 34.4% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $32.40 (+176.5%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$11.40 -
$14.51
Company Quality Score
45/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
51.1%
All Signals
- BEARISH: Price extended above range (+8.5% above its trading range)
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+34.4%)
- BULLISH: Trading 176.5% below Wall St target ($32.40)
Trading Range Analysis
30-Day Trading Range
$11.40 -
$14.51
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$11.25
Resistance Level
$16.69
Current Trend
Downtrend
Technical data as of
Jul 27, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-2.23
Wall Street Target
$32.40
(+176.5%)
Share & Embed Analysis
Last updated: July 28, 2026 12:14 PM ET
Data refreshes hourly during market hours. Next update: 1:14 PM
Data refreshes hourly during market hours. Next update: 1:14 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PMN showing a specific setup today?
Insider Activity (6 Months)
5
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Patrick D Kirwin
BUY
4000 shares
2026-04-22
Eugene Williams
BUY
2000 shares
2026-03-04
Eugene Williams
BUY
1000 shares
2026-03-02
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$86 | 59 HOLD |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$819 | 56 HOLD |
|
INSM
Insmed Inc |
STRONG BUY
21 analysts |
$196 | 46 HOLD |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$92 | 53 HOLD |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
18 analysts |
$267 | 58 HOLD |
